IP Library Granted Patent US 10,166,208
Granted Patent B2
US 10,166,208 · App. 15/876,181 · Granted Jan 1, 2019

Oral care composition

Inventor: Matthew Franco Myntti (St. Augustine, FL)
Assignee: Next Science IP Holdings Pty Ltd
A61K31/194A01N25/02A01N25/08A01N25/30A01N37/36A01N59/26A01N61/00A61K8/19A61K8/365A61K8/39A61K8/41A61K8/416A61K8/44A61K8/463A61K8/466A61K8/4926A61K8/4973A61K8/55A61K8/602A61K8/86A61K9/0014A61K9/0063A61K9/06A61K31/14A61K31/19A61K33/00A61K33/02A61K33/04A61K33/20A61K33/24A61K33/32A61K33/42A61K47/02A61K47/10A61K47/12A61K47/34A61L26/0066A61Q17/005A61K9/08A61L2300/404A61Q11/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,166,208
App. No.
15/876,181
Granted
Jan 1, 2019
Kind
B2
Abstract

An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.

Claims (20)

1. An oral care composition useful for treating a microbe-induced condition of the oral cavity of a subject in need thereof, said oral care composition consisting of (1) an oral rinse containing eucalyptol, thymol, menthol, and methyl salicylate in an alcohol vehicle, (2) an aqueous composition consisting of dissociation products of at least one base and a phosphate or sulfate in water, and (3) from 0.5 to 1.8 g/L of at least one cationic surfactant, said oral care composition having a pH of from 7.5 to 10 and an osmolarity of from 1.25 to 2.5 Osm/L.

2. The oral care composition of claim 1 having an osmolarity of from 1.33 to 2.25 Osm/L.

3. The oral care composition of claim 2 having an osmolarity of from 1.5 to 2 Osm/L.

4. The oral care composition of claim 3 having an osmolarity of 1.75±0.075 Osm/L.

5. The oral care composition of claim 1 having a pH of from 7.7 to 9.8.

6. The oral care composition of claim 5 having a pH of about 9±0.5 pH units.

7. The oral care composition of claim 6 having a pH of about 9±0.3 pH units.

8. The oral care composition of claim 1 wherein said cationic surfactant is present at from 0.75 to 1.5 g/L.

9. The oral care composition of claim 8 wherein said cationic surfactant is present at from 0.8 to 1.4 g/L.

10. The oral care composition of claim 1 wherein said at least one cationic surfactant comprises cetylpyridinium chloride.

11. The oral care composition of claim 1 wherein said at least one cationic surfactant is cetylpyridinium chloride.

12. An oral care composition useful for treating a microbe-induced condition of the oral cavity of a subject in need thereof, said oral care composition consisting of (1) an oral rinse containing eucalyptol, thymol, menthol, and methyl salicylate in an alcohol vehicle, (2) an aqueous composition consisting of dissociation products of an alkali metal hydroxide and a phosphate in water, and (3) from 0.5 to 1.8 g/L of cetylpyridinium chloride said oral care composition having a pH of from 7.5 to 10 and an osmolarity of from 1.5 to 2 Osm/L.

13. The oral care composition of claim 12 wherein said phosphate is a dihydrogen phosphate salt.

14. The oral care composition of claim 12 having a pH of 9±0.3 pH units.

15. The oral care composition of claim 12 wherein said cetylpyridinium chloride is present at from 0.75 to 1.5 g/L.

16. The oral care composition of claim 15 wherein said cetylpyridinium chloride is present at from 0.8 to 1.4 g/L.

17. The oral care composition of claim 12 having an osmolarity of 1.75±0.075 Osm/L.

18. An oral care composition useful for treating a microbe-induced condition of the oral cavity of a subject in need thereof, said oral care composition consisting of (1) an oral rinse containing eucalyptol, thymol, menthol, and methyl salicylate in an alcohol vehicle, (2) an aqueous composition consisting of dissociation products of an alkali metal hydroxide and a dihydrogen phosphate salt in water, and (3) from 0.75 to 1.5 g/L of cetylpyridinium chloride said oral care composition having a pH of from 7.5 to 10 and an osmolarity of from 1.5 to 2 Osm/L.

19. The oral care composition of claim 18 wherein said cetylpyridinium chloride is present at from 0.8 to 1.4 g/L.

20. The oral care composition of claim 18 having a pH of 9±0.3 pH units.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
Continuity (4)
Continuation 14350322
Provisional Application 61545108 · Oct 8, 2011
Provisional Application 61660649 · Jun 15, 2012
Related Publication 20180140567A1 · May 24, 2018
Cited By (1)
US 12,419,830